Vontobel Holding Ltd. Invests $2.71 Million in Astera Labs, Inc. (NASDAQ:ALAB)

Vontobel Holding Ltd. purchased a new position in Astera Labs, Inc. (NASDAQ:ALABFree Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 20,420 shares of the company’s stock, valued at approximately $2,705,000.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Legato Capital Management LLC increased its holdings in Astera Labs by 68.2% in the fourth quarter. Legato Capital Management LLC now owns 25,612 shares of the company’s stock worth $3,392,000 after buying an additional 10,386 shares during the last quarter. Peterson Wealth Services acquired a new position in Astera Labs in the fourth quarter worth approximately $1,208,000. Essex Financial Services Inc. increased its holdings in Astera Labs by 1.9% in the fourth quarter. Essex Financial Services Inc. now owns 24,939 shares of the company’s stock worth $3,303,000 after buying an additional 468 shares during the last quarter. Comprehensive Financial Planning Inc. PA acquired a new position in Astera Labs in the fourth quarter worth approximately $250,000. Finally, Entropy Technologies LP acquired a new position in Astera Labs in the fourth quarter worth approximately $1,742,000. Institutional investors and hedge funds own 60.47% of the company’s stock.

Wall Street Analysts Forecast Growth

ALAB has been the topic of a number of research reports. Northland Securities upgraded Astera Labs from a “market perform” rating to an “outperform” rating and set a $120.00 price objective on the stock in a report on Tuesday, January 28th. JPMorgan Chase & Co. increased their price target on Astera Labs from $70.00 to $110.00 and gave the company an “overweight” rating in a report on Tuesday, November 5th. Craig Hallum increased their price target on Astera Labs from $105.00 to $125.00 and gave the company a “buy” rating in a report on Tuesday, February 11th. Northland Capmk upgraded Astera Labs from a “hold” rating to a “strong-buy” rating in a report on Tuesday, January 28th. Finally, Stifel Nicolaus increased their price target on Astera Labs from $100.00 to $150.00 and gave the company a “buy” rating in a report on Monday, January 6th. One investment analyst has rated the stock with a hold rating, eleven have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Buy” and a consensus target price of $115.33.

View Our Latest Research Report on ALAB

Insider Buying and Selling

In related news, Director Manuel Alba sold 63,000 shares of the firm’s stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $102.94, for a total value of $6,485,220.00. Following the completion of the transaction, the director now directly owns 471,863 shares of the company’s stock, valued at $48,573,577.22. This trade represents a 11.78 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Michael Truett Tate sold 167,000 shares of the firm’s stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $102.94, for a total value of $17,190,980.00. Following the completion of the transaction, the chief financial officer now directly owns 1,595,888 shares of the company’s stock, valued at approximately $164,280,710.72. This trade represents a 9.47 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 639,244 shares of company stock valued at $67,669,886 over the last ninety days.

Astera Labs Stock Performance

Shares of Astera Labs stock opened at $87.85 on Monday. The company’s fifty day simple moving average is $120.17 and its 200-day simple moving average is $83.51. Astera Labs, Inc. has a 1 year low of $36.22 and a 1 year high of $147.39.

Astera Labs (NASDAQ:ALABGet Free Report) last issued its earnings results on Monday, February 10th. The company reported $0.10 EPS for the quarter, missing the consensus estimate of $0.26 by ($0.16). Astera Labs had a negative return on equity of 15.57% and a negative net margin of 30.69%. Equities analysts forecast that Astera Labs, Inc. will post -0.45 earnings per share for the current year.

Astera Labs Profile

(Free Report)

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

Featured Stories

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALABFree Report).

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.